Provided by Tiger Trade Technology Pte. Ltd.

Whitehawk Therapeutics, Inc.

4.73
-0.1000-2.07%
Post-market: 4.730.00000.00%19:30 EDT
Volume:226.21K
Turnover:1.07M
Market Cap:269.65M
PE:-4.25
High:4.94
Open:4.87
Low:4.64
Close:4.83
52wk High:5.50
52wk Low:1.68
Shares:57.01M
Float Shares:28.74M
Volume Ratio:0.82
T/O Rate:0.79%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1137
EPS(LYR):-0.3328
ROE:-44.98%
ROA:-28.70%
PB:1.47
PE(LYR):-14.21

Loading ...

TD Cowen Remains a Hold on Whitehawk Therapeutics (WHWK)

TIPRANKS
·
Aug 07

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 07

Whitehawk Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Whitehawk Therapeutics Posts Corporate Deck Highlighting ADC Platform and Phase 1 Pipeline Progress

Reuters
·
Aug 06

Whitehawk Q2 FY26 Net Loss Narrows to $16.64 Million

Reuters
·
Aug 06

WhiteHawk Therapeutics Inc Q2 Operating Expenses USD 18.109 Million

THOMSON REUTERS
·
Aug 06

Press Release: Whitehawk Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights

Dow Jones
·
Aug 06

Whitehawk Therapeutics Inc Expected to Post a Loss of 30 Cents a Share - Earnings Preview

Reuters
·
Aug 03

Biocytogen, Whitehawk Therapeutics Team up on Bispecific Antibody-drug Conjugate Development

Reuters
·
Jul 07

Biocytogen and Whitehawk Therapeutics Enter Global Collaboration for Bispecific Antibody ADC Development

THOMSON REUTERS
·
Jul 07

Whitehawk Therapeutics Inc: Additional Financial Terms were not Disclosed

THOMSON REUTERS
·
Jul 07

Whitehawk Therapeutics - Biocytogen to Receive Upfront Payment, Milestone Payments, and Low Single-digit Royalties

THOMSON REUTERS
·
Jul 07

Whitehawk Therapeutics Initiated at Buy by B. Riley Securities

Dow Jones
·
Jun 25

Whitehawk Therapeutics Inc : B. Riley Initiates Coverage with Buy Rating; Target Price $10

THOMSON REUTERS
·
Jun 25

Whitehawk Therapeutics shareholders ratified BDO USA as independent auditor

Reuters
·
Jun 13

Whitehawk Therapeutics presents real-world analysis on SEZ6

TIPRANKS
·
Jun 01

Whitehawk says Tempus-backed analysis supports SEZ6 as SCLC target for HWK-206 ADC ahead of mid-2026 IND

Reuters
·
May 31

BRIEF-Whitehawk Therapeutics - Files To Offer And Resell Up To 22.32 Million Shares Of Common Stock By Selling Stockholders

Reuters
·
May 30

WhiteHawk Therapeutics - Files to Offer and Resell up to 22.32 Mln Shares of Common Stock by Selling Stockholders - SEC Filing

THOMSON REUTERS
·
May 30

Whitehawk Therapeutics CEO to present at Jefferies Global Healthcare Conference

Reuters
·
May 29